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Bixin is the main carotenoid found in annatto seeds (Bixa orellana L.) and is responsible for their reddish-
orange color. The antioxidant properties of this compound are associated with its ability to scavenge free
radicals, which may reduce damage and protect tissues against toxicity caused by anticancer drugs such
as cisplatin. In this study, the genotoxicity and antigenotoxicity of bixin on cisplatin-induced toxicity in
PC12 cells was assessed. Cytotoxicity was evaluated using the MTT assay, mutagenicity, genotoxicity, and
protective effect of bixin were evaluated using the micronucleus test and comet assay. PC12 cells were
treated with bixin (0.05, 0.08, and 0.10 lg/mL), cisplatin (0.1 lg/mL) or a combination of both bixin
and cisplatin. Bixin was neither cytotoxic nor genotoxic compared to the controls. In the combined treat-
ment bixin signiﬁcantly reduced the percentage of DNA in tail and the frequency of micronuclei induced
by cisplatin. This result suggests that bixin can function as a protective agent, reducing cisplatin-induced
DNA damage in PC12 cells, and it is possible that this protection could also extend to neuronal cells. Fur-
ther studies are being conducted to better understand the mechanisms involved in the activity of this
protective agent prior to using it therapeutically.
 2011 Elsevier Ltd. .Open access under the Elsevier OA license1. Introduction
Carotenoids are a family of fat-soluble pigments found in fruits
and vegetables. They are the most potent suppressors of biological
singlet O2 (Di Mascio et al., 1989). Carotenoids interact with singlet
O2 either via physical suppression, in which the energy of the ex-
cited singlet O2 molecule is transferred to the carotenoid and then
dissipated as heat, or by chemical suppression mechanisms, in
which the carotenoid is destroyed through the addition of O2 to
its double-bond system (Liebler, 1993). The antioxidant properties
of carotenoids have been suggested to be responsible for the mainsis block proliferating index;
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2007). These effects include a decreased risk of developing sores
and cataracts as well as several chronic degenerative diseases such
as cancer, cardiovascular disease and macular degeneration
(Lampe, 1999; Stanner et al., 2004).
Bixin is the main carotenoid found in the seeds of annatto trees
(Bixa orellana L.), which are native to tropical America and are cul-
tivated in the tropical regions of Central and South America, Africa
and Asia (Mercadante et al., 1997). This carotenoid is responsible
for the orange-red coloration of annatto seeds and their extracts
(Chisté et al., 2011). Annatto extract is widely used in the food
industry as a natural colorant in many formulations, including
ice cream, cheese, sausage, yogurt and margarine. It is also used
by the pharmaceutical and cosmetic industries (Rios et al., 2007).
Among the carotenoids, bixin is an efﬁcient suppressor of sin-
glet oxygen in ﬂuid solutions, with a molecular suppression rate
similar to that observed with b-carotene (Manitto et al., 1987; Rios
et al., 2007). b-Carotene may be involved in protecting cells and tis-
sues against the deleterious effects of free radicals, which cause
oxidative damage to DNA (Antunes et al., 2005; Collins, 2001).
Cisplatin [cis-diamminedichloroplatinum(II), cDDP] is one of
the most potent chemotherapeutic agents available and is highly
effective at treating several types of cancer, including ovarian,
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Wang and Lippard, 2005). However, treatment with cisplatin and
its analogs is often hindered by side effects, including nephrotoxi-
city, peripheral neurotoxicity, and ototoxicity (Knight et al., 2005).
While diuretics and the pre-hydration of patients undergoing
treatment have been shown to successfully control nephrotoxicity,
peripheral neurotoxicity remains as the principal dose-limiting
toxic effect (Lichtman et al., 2007; Polycarpe et al., 2004). The neu-
rological effects of cisplatin may be severe and affect the patient’s
quality of life, even long after treatment ends (Pace et al., 2003).
Cisplatin is capable of generating reactive oxygen species (ROS)
such as superoxide and hydroxyl radicals (Yoshida et al., 2003). It
has also been shown that chemotherapy with cisplatin causes a de-
crease the plasma concentrations of various antioxidants (Weijl
et al., 1998). This decrease can lead to a failure of the antioxidant
defense mechanisms against organ damage, which are mediated
by free radicals, and the subsequent mutagenic capability of cis-
platin. The genotoxicity of antitumor drugs to normal tissues can
lead to the induction of secondary malignancies. Several studies
have shown that the administration of antioxidants can reduce
the side effects associated with cisplatin (Antunes et al., 2000;
Leonetti et al., 2003; Pace et al., 2003; Weijl et al., 1997; Wozniak
et al., 2004; Yoshida et al., 2003), including neurotoxicity.
One of neuronal cell lines most frequently used to study neuro-
nal function is the cell line PC12 (pheocromocytoma from the adre-
nal glands of rats). These cells have many advantages over primary
cultures of neuronal cells, including the homogeneity of the cell
population (Piga et al., 2007). In our study, this neuronal cell line
was used to evaluate the possible cytotoxicity and genotoxicity
of bixin as well as its protective effects against cisplatin-induced
genotoxic damage.2. Materials and methods
2.1. Preparation of samples and reagents
Dry annatto seeds were collected in the city of Ribeirão Preto, São Paulo, Brazil.
Bixin was extracted from annatto seeds washed with ethyl acetate, hexane and
methanol. The solvents were completely evaporated in a roto-evaporator (Büchi
Labortechnik), and crystallization was performed with dichloromethane/ethanol
(1:4). Bixin crystals were formed with 95% purity and were stored under refrigera-
tion and protected from light until use (Rios and Mercadante, 2004).
Bixin was dissolved in dimethylsulfoxide (DMSO, Sigma Chemical Co., USA) at a
ﬁnal concentration of 0.4%. All solutions containing bixin were prepared immedi-
ately prior to use. Cisplatin (cDDP; CAS No. 15663-27-1) was acquired from Quiral
Química do Brasil S.A. (Platinil). All other reagents were of high purity.2.2. Cell line
A rat pheochromocytoma cell line (PC12 cells) from the American Type Culture
Collection (Rockville, MD, USA) was used in all experiments. The cells were cultured
in RPMI 1640 medium (Sigma–Aldrich Co.) at 37 C in a humidiﬁed incubator with
an atmosphere of 95% air and 5% CO2 (Thermo Electron Co.). The medium contained
10% heat-inactivated horse serum (Invitrogen, Brazil), 5% heat-inactivated fetal bo-
vine serum (Invitrogen) and 1% penicillin/streptomycin antibiotic mixture (Invitro-
gen). In all experiments, the cells were incubated 24 h before beginning bixin and/
or cisplatin treatments.2.3. MTT assay
The MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay
(a tetrazolium salt reduction assay) provides sensitive measurements of the normal
metabolic status of cells, particularly that of the mitochondrion, where measure-
ments reﬂect early cellular redox changes (Mosmann, 1983). PC12 cells
(1  105 cells/well in 96-well plates) were incubated at 37 C for 24 h with different
concentrations of bixin (0.05–20 lg/mL), cDDP (0.1 lg/mL) or a combination of
both (bixin + cDDP). A negative control containing only cells and a solvent control
(cells treated with 0.4% DMSO) were also evaluated. After treatment, the plates
were incubated in the MTT solution (ﬁnal concentration of 0.5 mg/mL) for 3 h.
The dark-blue formazan crystals that formed in intact cells were dissolved with
DMSO, and the absorbance at 570 nm was measured with a microenzyme-linkedimmunosorbent assay (ELISA) reader (Sigma). The results were expressed as the
percentage of MTT reduction relative to the absorbances measured from negative
control cells. All assays were performed in triplicate.2.4. Micronucleus test
The in vitro micronucleus (MN) test was conducted as described by Fenech
(2000) with slight modiﬁcation. Cells (1  106 in a 25 cm2 ﬂask) were incubated
24 h before treatment with cDDP (0.1 lg/mL), bixin (0.05, 0.08, or 0.10 lg/mL) or
a combination of both (bixin + cDDP); in the combined treatments, cisplatin was
added to the culture medium 1 h after bixin was added (25 h after the initial incu-
bation of the cells), and all treatments were set until harvest. The concentrations of
bixin used were established based on the results of the MTT assay (concentrations
of bixin with cell viability above 80%). A negative control (untreated culture) and
solvent control (culture of 0.4% DMSO-treated cells) were also evaluated.
Cytochalasin B (6 lg/mL) was added to arrest cytokinesis after 44 h of growth,
and the cells were harvested and placed in a cold hypotonic solution (1% sodium
citrate) and ﬁxed three times in cold methanol:acetic acid (3:1) 72 h after initiating
the culture. The initial addition of ﬁxative contained 1% formaldehyde, which en-
hances cytoplasm preservation. Slides were prepared and stained in a solution of
4% Giemsa dye (Sigma–Aldrich Co.) in phosphate buffer (pH 6.8) for 10 min. The
slides were coded and scored by light microscopy at 400 or 1000magniﬁcation,
as required. In three independent experiments, 2000 binucleated cells (BN) with
well-preserved cytoplasms were scored.
MN cells were identiﬁed according to the criteria previously published by Fen-
ech et al. (2003). The frequency of binucleated cells containing one or more MN was
also determined. As a measure of cell proliferation, the cytokinesis block proliferat-
ing index (CBPI) was calculated according to the following formula: CBPI = [MI + 2-
MII + 3(MIII + MIV)]/N, as proposed by Surrallés et al. (1995), where MI–MIV
represents the number of cells with 1–4 nuclei in a total of 500 cells. The capacity
of the bixin reduces the damage caused by cDDP was calculated according to
Manoharan and Banerjee (1985) and Waters et al. (1990) using the formula:
%R ¼ A B
A C  100
where %R is the reduction percentage, A the micronuclei (MN) frequency after treat-
ment with cDDP, B the MN frequency after treatment with the bixin and cDDP, and C
the MN frequency of negative control.2.5. Single-cell gel electrophoresis (SCGE, comet assay)
Comet assays were performed under alkaline conditions according to the meth-
ods of Singh et al. (1988) and Tice et al. (2000), with slight modiﬁcations. PC12 cells
seeded at 1  106 cells in a 25 cm2 ﬂask. To analyze the genotoxic effect, the cells
were treated with bixin or cisplatin for 4 h. And to analyze the antigenotoxic effect,
the cells were treated with bixin 1 h before treatment with cisplatin. A negative
control (untreated culture) and solvent control (culture of 0.4% DMSO-treated cells)
were also evaluated. The total treatment time was also 4 h. Microscope slides
(frosted) were covered by a thin layer of 1.0% normal-melting point agarose (Invit-
rogen), which was dissolved in Ca2+ and Mg2+-free PBS, at 60 C. Upon solidiﬁcation
of the agarose, 10 lL of a freshly prepared suspension of treated or control PC12
cells was mixed with 100 lL of low-melting-point agarose (0.5%, Sigma–Aldrich
Co) at 37 C. The cells were covered with a coverslip and incubated at 4 C for
10 min. After solidiﬁcation of the agarose, the coverslips were removed and the
slides were incubated in cold lysis solution (2.5 M NaCl, 100 mM EDTA, 10 mM Tris
[pH 10], 1% Triton X-100 and 10% DMSO) at 4 C overnight. After lysis, the slides
were placed in a horizontal electrophoresis unit containing alkaline electrophoretic
solution (300 mM NaOH and 1 mM EDTA, pH > 13) for 20 min at 4 C with an elec-
tric ﬁeld strength of 25 V (0.78 V/cm) and a current of 300 mA, which allows the
DNA to unwind, exposing alkali-labile sites. The slides were then washed with cold
neutralization buffer (0.4 M Tris–HCl, pH 7.5) for 15 min. After drying at room tem-
perature, the slides were stained with 30 lL ethidium bromide (20 lg/mL) and
immediately analyzed using a ﬂuorescence microscope (Axiostar plus, Zeiss, Ger-
many) equipped with a 515–560 nm excitation ﬁlter, a 590 nm barrier ﬁlter and
an integrated digital camera. Slides were evaluated using CometScore software (Tri-
Tek Corp., USA), and 100 randomly selected nucleoids (50 nucleoids from each rep-
licate slide) were analyzed per treatment. Three independent experiments were
performed. DNA damage was quantiﬁed by the percentage of DNA in the comet tail
(% DNA).2.6. Statistical methods
The results presented are expressed as the mean ± standard deviation of three
independent experiments (N = 3). The data were subjected to multiple variance
analysis (ANOVA) and the post hoc Tukey test, using GraphPad Prism 2.01 software.
A value of p < 0.05 was considered statistically signiﬁcant for all of the parameters
evaluated.
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3.1. Cytotoxicity of doxorubicin and bixin in tumor cell line PC12
The citotoxicity of PC12 cells treated with bixin was evaluated
by the MTT method. Cells were treated with bixin at concentra-
tions between 0.05 and 20.0 lg/mL. Two controls were used in
these experiments: a negative control (untreated cells) and a sol-
vent control (0.4% DMSO). The negative control was considered
to have a cell viability of 100%.
As shown in Fig. 1, only treatments with 0.05, 0.08 and 0.10 lg/
mL bixin were moderately cytotoxic (relative MTT activity > 80%).
After treatment with 0.3 lg/mL bixin, PC12 cells presented citotox-
icity above 50%. The solvent control was not statistically different
(p < 0.05) from the negative control, indicating that the solvent
did not interfere with the cytotoxicity of bixin.
Using the concentrations of bixin that were moderately cyto-
toxic, another experiment was performed to evaluate the effects
of this carotenoid on PC12 cells in combination with cisplatin
(Fig. 2). When cells were treated with bixin 1 h prior to the addi-
tion of cisplatin, there was no statistically signiﬁcant difference
(p > 0.05) when compared to treatment with cisplatin alone. The
concentration of cisplatin used (0.1 lg/mL) was determined in pre-
liminary experiments (Mendonça et al., 2009). This concentration
was chosen due to its low cytotoxicity (7%), sufﬁcient BN cell num-
bers and ability to induce high numbers of micronuclei in PC12
cells.
Based on this information about the citotoxicity of the bixin and
cisplatin in these cells, we studied the genotoxicity and antigeno-
toxicity of bixin (0.05, 0.08, and 0.1 lg/mL) using the micronucleus
test and the comet assay.
3.2. Micronucleus test
The parameters evaluated in the micronucleus test were as fol-
lows: the percentage of binucleated cells (BN), the cytokinesis
block proliferation index (CBPI) and the frequency of binucleated
cells with micronuclei (MN).
Treatment with cisplatin reduced the CBPI value compared to
the negative control, but this reduction was not signiﬁcant
(p > 0.05). This result reinforces the low cytotoxicity associated
with this concentration of cisplatin, which produced 56% BN cells.
This concentration of BN cells allowed us to perform an analysis of0
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Fig. 1. Cytotoxicity of PC12 cells after treatment for 24 h with different concentrations
expressed as the percentage of viable cells, with the viability of untreated control cells
⁄p < 0.05, relative to untreated cells.MN frequency. According to Fenech (2000), to analyze the fre-
quency of MN, the percentage of BN cells should not be less than
30%. Cisplatin treatment resulted in an 8-fold increase in MN-posi-
tive cells compared with the negative control (Table 1).
These results demonstrate that the CBPI values for the different
bixin treatments (0.05, 0.08, and 0.1 lg/mL) were not statistically
different (p > 0.05) in relation to the negative control and the sol-
vent control, and these concentrations were sufﬁcient for BN cells
to be analyzed for MN frequency (Table 1). As shown in Table 1, the
number of MN in cells treated with bixin increased with the
increasing concentrations evaluated (8.7, 12.0, and 18.3, respec-
tively), but there was no signiﬁcant difference (p > 0.05) compared
to the negative control and solvent control. These results suggest
that bixin is not genotoxic to PC12 cells at the concentrations
evaluated.
Based on the results presented above, we evaluated the protec-
tive effects of bixin on genotoxicity induced by cisplatin in PC12
cells (Fig. 3 and Table 1).
Cells treated with bixin and cisplatin were not statistically dif-
ferent (p > 0.05) in terms of CBPI value from the negative control
and cells treated with DMSO + cisplatin. All treatments had a per-
centage of BN cells sufﬁcient for analysis of the number of micro-
nuclei (Table 1). The micronucleus frequency of cells pretreated
with 0.05, 0.08 and 0.10 lg/mL bixin in combination with cisplatin
resulted in an 2 to 3-fold decrease signiﬁcantly (p < 0.05) in MN-
positive cells compared the positive control (DMSO + 0.1 lg/mL
cisplatin). The largest reduction was observed in the pre-treatment
with 0.1 lg/mL bixin (Table 1).3.3. Comet assay
The comet assay was used to analyze the percentage of DNA in
the tail; the results are presented in Fig. 3. Bixin alone had no geno-
toxic effect, and treatment with 0.08 and 0.1 lg/ml signiﬁcantly re-
duced DNA migration compared with the solvent control, DMSO
(p < 0.05). When considering genotoxicity, bixin did not induce
DNA damage compared with DMSO alone.
There was no signiﬁcant effect of cisplatin on DNA migration
when compared with DMSO alone (Fig. 3). However, pretreatment
with a combination of bixin and cisplatin caused a statistically sig-
niﬁcant decrease (p < 0.05) in DNA migration compared with cis-
platin treatment alone.0.80 1.00 2.50 5.00 10.00 15.00 20.00
 (µg/mL)
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*
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of bixin. PC12 cell cytotoxicity was determined using the MTT assay. Values are
set at 100%. Data are mean and S.D. values from three independent experiments.
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Fig. 2. Cytotoxicity of PC12 cells after treatment for 24 h with bixin, cisplatin or combined treatment with bixin and cisplatin. PC12 cell cytotoxicity was determined using the
MTT assay. Data are mean and S.D. values from three independent experiments. ⁄p < 0.05, relative to cisplatin treatment. cDDP: cisplatin (0.1 lg/mL).
Table 1
Induction of micronuclei by bixin, cisplatin or associated treatment of bixin with cisplatin in PC12 cells.
Treatments (lg/mL) Total cells
scored
%
BN
CBPI
mean ± S.D.
Binucleated micronucleated
cells
Binucleated micronucleated cells/1000 BN cells
Mean ± S.D.
Reduction
(%)
Negative control 6000 63 1.65 ± 0.17 64 10.7 ± 0.6 –
DMSO 0.4% 6000 62 1.65 ± 0.21 86 14.3 ± 1.5 –
BXN 0.05 6000 62 1.63 ± 0.15 52 8.7 ± 1.5 –
BXN 0.08 6000 59 1.61 ± 0.18 72 12.0 ± 1.0 –
BXN 0.1 6000 51 1.53 ± 0.21 109 18.3 ± 6.5 –
DMSO 0.4% + cDDP
0.1
6000 56 1.56 ± 0.11 540 92.8 ± 12.4* –
BXN 0.05 + cDDP
0.1
6000 44 1.45 ± 0.30 240 40.0 ± 6.2*,# 67.2
BXN 0.08 + cDDP
0.1
6000 49 1.50 ± 0.29 170 28.3 ± 2.1*,# 82.1
BXN 0.10 + cDDP
0.1
6000 45 1.46 ± 0.30 156 26.0 ± 1.0*,# 85.1
Abbreviations: BN: binucleate cells; MN: micronuclei; CBPI: cytocinesis-block proliferating index; cDDP: cisplatin; BXN: bixin. Data were represented as mean of three
independent experiments. Each experiment was done in triplicate.
* Statistically signiﬁcant difference in comparison with Negative control and DMSO (p < 0.05).
# Statistically signiﬁcant difference in comparison with DMSO + cDDP (p < 0.05).
Fig. 3. Percentage of DNA damage in PC12 cells treated for 4 h with bixin, cisplatin or combined treatment with bixin and cisplatin. ⁄p < 0.05, relative to DMSO treatment and
⁄⁄p < 0.05, relative to DMSO + cDDP treatment. cDDP: cisplatin.
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The mechanism by which cisplatin induces neurotoxicity is still
unclear. This peripheral neuropathy may be due in part to oxida-tive stress (Lee et al., 2008). Thus, an antioxidant able to neutralize
or reduce the action of ROS during treatment with cisplatin may
reduce the drug’s toxic effects on normal cells. The carotenoid bix-
in may contribute to protecting these cells against the deleterious
G.C. Santos et al. / Food and Chemical Toxicology 50 (2012) 335–340 339effects of free radicals (Di Mascio et al., 1990), as it is an effective
scavenger of singlet oxygen molecules, and it has the potential to
act speciﬁcally on DNA damage induced by free radicals or other
compounds capable of generating such damage (Rios et al.,
2009). Leonetti et al. (2003) suggested that antioxidants do not
interfere with the antitumor activity of cisplatin and that they
are safe to use during chemotherapy. They found that alpha-
tocopherol protected against the systemic toxicity and neurotox-
icity induced by cisplatin without interfering with antitumor activ-
ity in both in vitro and in vivo systems.
Although widely used as a food-coloring agent with antioxidant
activity, there are still only a few, limited studies on the biological
effects of bixin.
All concentrations of bixin tested inhibited PC12 tumor cell
growth, as indicated by the MTT assay, although 0.05, 0.08, and
0.1 lg/mL were only moderately cytotoxic (relative MTT
activity > 80%).
Reddy et al. (2005) evaluated the cell growth inhibition induced
by various naturally colored foods, including bixin, in the tumor
cell lines HCT-116 (colon), AGS (stomach), SF-268 (CNS), and
NCI-H460 (lung). Bixin had an IC50 of 33, 49, 45, and 39 lg/mL in
cell lines from colon cancer, the central nervous system, stomach
and lung, respectively. Tibodeau et al. (2010) also observed the
cytotoxic effects of bixin in a variety of cancer cell lines such as
U2OS (osteosarcoma), PC3 (prostate), HCT-116 (colon), MCF7
(breast), DRO (anaplastic thyroid), and BHP5–16 (papillary thy-
roid), and obtained IC50 values of 4–20 lg/mL after 24 h of expo-
sure. This group also demonstrated that bixin rapidly induced
ROS in a dose- and time-dependent manner based on ﬂuorescence
activated cell sorting (FACS) experiments, suggesting that the ROS
generation induced by bixin contributes to its cytotoxicity. Like
other dietary phytochemicals, bixin has pro-oxidant activity in
addition to its antioxidant activity, depending on the dosage and
chemical environment. Thus, depending on the concentration used,
bixin can act as a pro-oxidant, causing cell death.
When PC12 cells were pretreated with a combination of cDDP
and bixin, we observed that this combination did not change the
individual cytotoxicity proﬁles of these compounds, indicating that
bixin does not increase the cytotoxicity of cDDP under the evalu-
ated conditions.
According to Zeiger (2007), for a substance to be classiﬁed as
antigenotoxic/antimutagenic, it must ﬁrst be evaluated for geno-
toxicity/mutagenicity. In our study, the three concentrations of
bixin (0.05, 0.08, and 0.1 lg/mL) that maintained cell viability
above 80% were evaluated using the comet assay and the micronu-
cleus test to determine the compound’s genotoxic potential prior
to assessing it as a potential protective agent.
In the micronucleus test, the concentrations of bixin assayed
did not produce effects that were statistically different (p > 0.05)
from the solvent control. In the comet assay, bixin did not induce
DNA damage in PC12 cells but actually reduced damage when
compared with the baseline solvent control, as shown by the de-
creased DNA fragmentation in bixin-treated cells. These results
indicate that under our experimental conditions, bixin is not geno-
toxic to PC12 cells.
With respect to cDDP, our comet assay results indicated that
this drug did not signiﬁcantly affect the migration of DNA when
compared with the DMSO control. This migration is inhibited by
interstrand DNA crosslinks and facilitated by intrachain crosslinks
(Tice et al., 2000; Wozniak et al., 2004). Thus, the existence of
interstrand crosslinks inhibits the electrophoretic mobility of
DNA, reducing the amount of DNA found in tails (Almeida et al.,
2006). Wozniak et al. (2004) demonstrated that cDDP can induce
DNA fragmentation and can also cause crosslinking in DNA from
human lymphocytes and K562 cells (human chronic myelogenous
leukemia).Overall, we observed potential protective effects associated
with bixin. This conclusion is based on the results of the micronu-
cleus test, which showed a difference in the frequency of micronu-
clei in cells treated with bixin and cDDP compared to
DMSO + cDDP treatment. Treatment with cDDP and bixin did not
decrease the frequency of micronuclei to the values observed in
the negative control (p < 0.05), but the values were signiﬁcantly
decreased (p < 0.05) when compared with those for cells treated
with DMSO + cDDP. Similarly, other studies have shown that bixin
has a protective effect against radiation damage and against cDDP-
induced clastogenicity in rats (Silva et al., 2001; Thresiamma et al.,
1998).
The mechanisms by which carotenoids induce genotoxicity
and/or antigenotoxicity are not well understood. The antioxidant
mechanism in vitro might involve the direct inhibition of ROS gen-
eration or sequestering of free radicals (Aruoma, 2003). Rios et al.
(2009) assessed the modulation of ROS produced by the interaction
of cDDP and DNA in a human cell-free experimental model using
bixin. The results revealed that the ROS generated by the cDDP/
DNA interaction were inhibited by 40 lg/mL of bixin (superoxide
anion generation at 82% and total ROS generation at 42%).
Because bixin is used as a natural colorant in various foods, its
bioactivity and toxicity have been studied previously, including its
effect on lipid peroxidation and carcinogenesis (Kiokias and
Gordon, 2003; Reddy et al., 2005; Silva et al., 2001). Additionally,
it is thought that bixin suppresses the formation and proliferation
of tumors. This effect is probably due to both its antioxidant effects
and its inhibition of DNA breaks and lipid peroxidation.5. Conclusion
The antioxidant effects produced by the ability of bixin to inter-
cept free radicals generated by cDDPmay have contributed, at least
partially, to the antigenotoxic effects observed in this study. How-
ever, more studies are being conducted to better understand the
mechanisms underlying the protective activity of this carotenoid.6. Conﬂict of Interest
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